articleThe LancetJun 1, 2002Closed access

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

MBM BaumAUAman U. BudzarJCJ CuzickJFJF ForbesJHJoanna Houghton

Breast Cancer Care · Cancer Research UK

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,958
total citations
FWCI
100.53
Percentile
100%
References
27
Citations per year

Authors

8

Topics & keywords

Topics
Keywords
  • Anastrozole
  • Tamoxifen
  • Medicine
  • Breast cancer
  • Internal medicine
  • Hazard ratio
  • Oncology
  • Endometrial cancer
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.